Mismatch repair defects in cancer

Current Opinion in Genetics and Development

Volumn 10, Issue 2, 2000, Pages 157-161

  Jiricny, Josef ^a   Nyström Lahti, Minna ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BASE MISPAIRING; CANCER GENETICS; COLORECTAL CANCER; DIAGNOSTIC TEST; DNA REPAIR; ENDOMETRIUM CANCER; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0343674773     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(00)00066-6     Document Type: Review

References (62)

1. •].
2. Peltomaki P., Vasen H.F. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 113:1997;1146-1158.
3. Kolodner R.D., Marsischky G.T. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev. 9:1999;89-96.
4. Modrich P. Mechanisms and biological effects of mismatch repair. Annu Rev Genet. 25:1991;229-253.
5. Kolodner R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 10:1996;1433-1442.
6. Modrich P., Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem. 65:1996;101-133.
7. Crouse G. Mismatch repair systems in Saccharomyces cerevisiae. Nickoloff J.A., Hoekstra M.F. DNA Damage and Repair, Vol. 1: DNA Repair in Prokaryotes and Lower Eukaryotes. 1997;411-448 Humana Press Inc, Totowa, NJ.
8. Modrich P. Strand-specific mismatch repair in mammalian cells. J Biol Chem. 272:1997;24727-24730.
9. Jiricny J. Replication errors: cha(lle)nging the genome. EMBO J. 17:1998;6427-6436.
10. Jiricny J. Eukaryotic mismatch repair: an update. Mutat Res. 409:1998;107-121.
11. Fishel R., Wilson T. MutS homologs in mammalian cells. Curr Opin Genet Dev. 7:1997;105-113.
12. •].
13. •].
14. •] demonstrate that hMutSα forms a sliding clamp on heteroduplex DNA following an ATP- and magnesium-binding-induced conformational change. The authors postulate the role of this factor in signal transduction.
15. Allen D.J., Makhov A., Grilley M., Taylor J., Thresher R., Modrich P., Griffith J.D. MutS mediates heteroduplex loop formation by a translocation mechanism. EMBO J. 16:1997;4467-4476.
16. Dao V., Modrich P. Mismatch-, MutS-, MutL-, and helicase II-dependent unwinding from the single-strand break of an incised heteroduplex. J Biol Chem. 273:1998;9202-9207. This paper demonstrates that the MMR process begins at a strand interruption, where the unwinding helicases and exonucleases are loaded with the help of MutL.
17. Räschle M., Marra G., Nyström-Lahti M., Schär P., Jiricny J. Identification of hMutLβ, a heterodimer of hMLH1 and hPMS1. J Biol Chem. 274:1999;32368-32375.
18. Li G.M., Modrich P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc Natl Acad Sci USA. 92:1995;1950-1954.
19. •]).
20. Bhattacharyya N.P., Skandalis A., Ganesh A., Groden J., Meuth M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA. 91:1994;6319-6323.
21. Akiyama Y., Sato H., Yamada T., Nagasaki H., Tsuchiya A., Abe R., Yuasa Y. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res. 57:1997;3920-3923.
22. Miyaki M., Konishi M., Tanaka K., Kikuchi-Yanoshita R., Muraoka M., Yasuno M., Igari T., Koike M., Chiba M., Mori T. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet. 17:1997;271-272.
23. Wu Y., Berends M.J., Mensink R.G., Kempinga C., Sijmons R.H., van Der Zee A.G., Hollema H., Kleibeuker J.H., Buys C.H., Hofstra R.M. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mtations. Am J Hum Genet. 65:1999;1291-1298.
24. Kolodner R.D., Tytell J.D., Schmeits J.L., Kane M.F., Gupta R.D., Weger J., Wahlberg S., Fox E.A., Peel D., Ziogas A.et al. Line MSH6 mutations in colorectal cancer families. Cancer Res. 59:1999;5068-5074.
25. Wijnen J., de Leeuw W., Vasen H., van der Klift H., Moller P., Stormorken A., Meijers-Heijboer H., Lindhout D., Menko F., Vossen S.et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet. 23:1999;142-144. This paper describes germline mutations in hMSH6 and also notes the apparent propensity of female patients with these mutations to endometrial cancers.
26. Papadopoulos N., Nicolaides N.C., Wei Y.F., Ruben S.M., Carter K.C., Rosen C.A., Haseltine W.A., Fleischmann R.D., Fraser C.M., Adams M.D. Mutation of a mutL homolog in hereditary colon cancer. Science. 263:1994;1625-1629.
27. Baker S.M., Bronner C.E., Zhang L., Plug A.W., Robatzek M., Warren G., Elliott E.A., Yu J., Ashley T., Arnheim N.et al. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell. 82:1995;309-319.
28. Prolla T.A., Baker S.M., Harris A.C., Tsao J.L., Yao X., Bronner C.E., Zheng B., Gordon M., Reneker J., Arnheim N.et al. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet. 18:1998;276-279.
29. de Wind N., Dekker M., Berns A., Radman M., te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell. 82:1995;321-330.
30. Reitmair A.H., Redston M., Cai J.C., Chuang T.C., Bjerknes M., Cheng H., Hay K., Gallinger S., Bapat B., Mak T.W. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res. 56:1996;3842-3849.
31. de Wind N., Dekker M., van Rossum A., van der Valk M., te Riele H. Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res. 58:1998;248-255.
32. Baker S.M., Harris A.C., Tsao J.L., Flath T.J., Bronner C.E., Gordon M., Shibata D., Liskay R.M. Enhanced intestinal adenomatous polyp formation in Pms2-/-;Min mice. Cancer Res. 58:1998;1087-1089.
33. Edelmann W., Yang K., Umar A., Heyer J., Lau K., Fan K., Liedtke W., Cohen P.E., Kane M.F., Lipford J.R.et al. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell. 91:1997;467-477.
34. -/- animals developed tumours, albeit mainly lymphomas. The double knock-out animals developed the expected intestinal tumours, thus substantiating the hypothesis that the inactivation of the hMSH3 and hMSH6 genes is equivalent to hMSH2 loss.
35. •]).
36. •].
37. •] describe the identification of the first homozygous hMLH1 mutants. The children were offspring of marriages between first cousins in HNPCC families and presented with leukemias and/or lymphomas, as well as neurofibromatosis at an early age.
38. Shimodaira H., Filosi N., Shibata H., Suzuki T., Radice P., Kanamaru R., Friend S.H., Kolodner R.D., Ishioka C. Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nat Genet. 19:1998;384-389. The authors describe a functional assay of hMLH1 mutations, which is based on the expression of the mutated protein in MMR-proficient yeast. Wild-type hMLH1 interferes with the endogenous MMR process and brings about a mutator phenotype, but hMLH1 variants carrying pathogenic mutations can be expressed in the host yeast strains without apparent deleterious effects.
39. Clark A.B., Cook M.E., Tran H.T., Gordenin D.A., Resnick M.A., Kunkel T.A. Functional analysis of human MutSα and MutSβ complexes in yeast. Nucleic Acids Res. 27:1999;736-742.
40. Drotschmann K., Clark A.B., Kunkel T.A. Mutator phenotypes of common polymorphisms and missense mutations in MSH2. Curr Biol. 9:1999;907-910.
41. Shcherbakova P.V., Kunkel T.A. Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations. Mol Cell Biol. 19:1999;3177-3183.
42. Guerrette S., Wilson T., Gradia S., Fishel R. Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer. Mol Cell Biol. 18:1998;6616-6623.
43. Guerrette S., Acharya S., Fishel R. The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chem. 274:1999;6336-6341.
44. Pang Q., Prolla T.A., Liskay R.M. Functional domains of the Saccharomyces cerevisiae Mlh1p and Pms1p DNA mismatch repair proteins and their relevance to human hereditary nonpolyposis colorectal cancer-associated mutations. Mol Cell Biol. 17:1997;4465-4473.
45. D'Atri S., Tentori L., Lacal P.M., Graziani G., Pagani E., Benincasa E., Zambruno G., Bonmassar E., Jiricny J. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol. 54:1998;334-341. The first report of the involvement of MMR proteins in DNA damage signalling and apoptosis. The authors show that treatment of MMR-proficient TK6 cells induces p53, p21 and apoptosis, but that the MMR-deficient near isogenic line MT1 was resistant to this treatment and did not induce p53.
46. Hickman M.J., Samson L.D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci USA. 96:1999;10764-10769.
47. Duckett D.R., Bronstein S.M., Taya Y., Modrich P. hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage. Proc Natl Acad Sci USA. 96:1999;12384-12388.
48. Wu J., Gu L., Wang H., Geacintov N.E., Li G.M. Mismatch repair processing of carcinogen-dna adducts triggers apoptosis. Mol Cell Biol. 19:1999;8292-8301.
49. Karran P., Hampson R. Genomic instability and tolerance to alkylating agents. Cancer Surveys. 28:1996;69-85.
50. Fink D., Aebi S., Howell S.B. The role of DNA mismatch repair in drug resistance. Clin Cancer Res. 4:1998;1-6.
51. Fink D., Nebel S., Norris P.S., Aebi S., Kim H.K., Haas M., Howell S.B. The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells. Br J Cancer. 77:1998;703-708.
52. •]).
53. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., Jessup J.M., Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57:1997;808-811.
54. Herman J.G., Umar A., Polyak K., Graff J.R., Ahuja N., Issa J.P., Markowitz S., Willson J.K., Hamilton S.R., Kinzler K.W.et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA. 95:1998;6870-6875.
55. Veigl M.L., Kasturi L., Olechnowicz J., Ma A., Lutterbaugh J.D., Periyasamy S., Li G.M., Drummond J., Modrich P.L., Sedwick W.D., Markowitz S.D. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA. 95:1998;8698-8702.
56. Esteller M., Catasus L., Matias-Guiu X., Mutter G.L., Prat J., Baylin S.B., Herman J.G. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol. 155:1999;1767-1772.
57. Wheeler J.M., Beck N.E., Kim H.C., Tomlinson I.P., Mortensen N.J., Bodmer W.F. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. Proc Natl Acad Sci USA. 96:1999;10296-102301.
58. Cunningham J.M., Christensen E.R., Tester D.J., Kim C.Y., Roche P.C., Burgart L.J., Thibodeau S.N. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58:1998;3455-3460.
59. Kuismanen S.A., Holmberg M.T., Salovaara R., Schweizer P., Aaltonen L., de la Chapelle A., Nyström-Lahti M., Peltomäki P. Epigenetic phenotypes distinguish microsatellite-stable and-unstable colorectal cancers. Proc Natl Acad Sci USA. 96:1999;12661-12666.
60. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., Issa J.P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 72:1998;141-196.
61. •]).
62. Fleisher A.S., Esteller M., Wang S., Tamura G., Suzuki H., Yin J., Zou T.T., Abraham J.M., Kong D., Smolinski K.N.et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 59:1999;1090-1095.